| Curcumin loaded dendrimers specifically reduce viability of glioblastoma cell lines J Gallien, B Srinageshwar, K Gallo, G Holtgrefe, S Koneru, PS Otero, ... Molecules 26 (19), 6050, 2021 | 27 | 2021 |
| Disease severity of respiratory syncytial virus compared with COVID-19 and influenza among hospitalized adults aged≥ 60 years—IVY network, 20 US States, February 2022–May 2023 D Surie MMWR. Morbidity and mortality weekly report 72, 2023 | 20 | 2023 |
| Effectiveness of monovalent mRNA COVID-19 vaccination in preventing COVID-19–associated invasive mechanical ventilation and death among immunocompetent adults during the … J DeCuir MMWR. Morbidity and mortality weekly report 72, 2023 | 17 | 2023 |
| Interim Effectiveness of Updated 2023–2024 (Monovalent XBB. 1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and … J DeCuir MMWR. Morbidity and Mortality Weekly Report 73, 2024 | 10 | 2024 |
| Silencing of the mutant huntingtin gene through CRISPR-Cas9 improves the mitochondrial biomarkers in an in vitro model of Huntington’s disease GL Dunbar, S Koneru, N Kolli, M Sandstrom, P Maiti, J Rossignol Cell Transplantation 28 (4), 460-463, 2019 | 8 | 2019 |
| Drug utilization evaluation of bronchial asthma in tertiary care hospital B Michael, N James, S Sreena, K Sindhuja, BK Nanjwade World J Pharm Pharm Sci 5 (2), 1075-91, 2016 | 7 | 2016 |
| Vaccine effectiveness against influenza A–associated hospitalization, organ failure, and death: United States, 2022–2023 NM Lewis, Y Zhu, ID Peltan, M Gaglani, T McNeal, S Ghamande, ... Clinical infectious diseases 78 (4), 1056-1064, 2024 | 3 | 2024 |
| Gut microbiome and its clinical implications: exploring the key players in human health S Koneru, V Thiruvadi, M Ramesh Current opinion in infectious diseases 36 (5), 353-359, 2023 | 2 | 2023 |
| Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the … J DeCuir, D Surie, Y Zhu, AS Lauring, M Gaglani, T McNeal, S Ghamande, ... medRxiv, 2024.01. 07.24300910, 2024 | 1 | 2024 |
| Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults D Surie, KA Yuengling, J DeCuir, Y Zhu, AS Lauring, M Gaglani, ... JAMA Network Open 7 (4), e244954-e244954, 2024 | | 2024 |
| Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness—United States AM Frutos MMWR. Morbidity and mortality weekly report 73, 2024 | | 2024 |
| CRISPR/Cas9 Mediated Gene Knockout in Adult Rat Astrocytes to Inhibit Notch, GSK-3 beta, and BMP Cell Signaling Pathways A Poudel, B Srinageshwar, E Nisper, MJ King, S Koneru, RC Schalau, ... CELL TRANSPLANTATION 32, 19-19, 2023 | | 2023 |
| Ovine-Sourced GM1 Ganglioside Reduces Motor Deficits and Elevates BDNF Levels in the R6/2 Mouse Model of Huntington's Disease S Koneru, M Resk, N Fettinger, K Olson, O Kacherian, C Malkowski, ... CELL TRANSPLANTATION 31, 2022 | | 2022 |
| Relative Efficacy of Ovine and Bovine Sources of GM1 Ganglioside for Treating Behavioral Deficits, Neuropathology, and Longevity in the R6/2 Mouse Model of Huntington's Disease S Koneru Central Michigan University, 2022 | | 2022 |
| Comparison Between Ovine and Bovine Sources of GM1 Ganglioside as a Treatment for Behavioral Deficits in the YAC128 Mouse Model of Huntington's Disease S Koneru Central Michigan University, 2020 | | 2020 |
| In Vivo Delivery of Large Plasmids and CRISPR-Cas9 to Edit GFP Gene Using Dendrimer Nanoparticles B Srinageshwar, MN Florendo, NM Munro, BS Macdonald, L Dehart, ... CELL TRANSPLANTATION 28 (4), 485-486, 2019 | | 2019 |
| TO STUDY THE TREATMENT PATTERN, OUTCOME AND ADVERSE DRUG REACTIONS OF ANTICANCER DRUGS IN LUNG CANCER PATIENTS IN TERTIARY CARE HOSPITAL S Koneru, MK Unnikrishnan, G Thunga | | 2016 |
| CHOICE OF ANTIHYPERTENSIVE AND ITS EFFECTS ON DIABETIC-HYPERTENSIVE POPULATION AN Rockin, T Das, J Thomas, K Sindhuja, BK Nanjwade | | 2016 |
Julien RossignolCentral Michigan UniversityAdresse e-mail validée de cmich.edu
